Anzeige / WerbungFinde mehr Informationen auf Youtube und axinocapital.de / axino.comEin starker US-Dollar bremst normalerweise Rohstoffe - doch aktuell steigen Gold und Kupfer trotzdem. Warum? Ein ge ...
The Slovak authorities have yesterday 30 March 2025 confirmed an outbreak of Foot and Mouth Disease (FMD) in a livestock of 3,487 animals on FirstFarms' farm in Plavecký Stvrtok, Slovakia.Due to the ...
Additional funding of US$2,000,000 underscores continued support of Volt's proprietary direct lithium extraction ("DLE") technology.Accelerating Domestic Critical ...
The General Meeting of Shareholders of AB Å iauliu Bankas unanimously agreed to decision to change the bank's name to AB Artea bankas. It is expected that the Bank will start operating ...
Tivoxavir marboxil's potential as a single dose therapeutic agent for bird flu supported by significant antiviral activity in three well accepted animal models and positive Phase 1 data Ongoing FDA ...
Lead program investigating MT-601 in patients with refractory lymphomas, including anti-CD19 CAR-T cell therapy, demonstrated safety and efficacy in 9 patients with 78% having objective responses, inc ...
Earnings Call Webcast to Discuss 2024 Fourth Quarter and Full Year Financial Results Scheduled to Post to Corporate Website by Wednesday, April 2, 2025 NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) ...
NEW YORK CITY (dpa-AFX) - Halozyme Therapeutics, Inc. (HALO), Monday announced that Bristol Myers Squibb (BMY) received a positive opinion from the Committee for Medicinal Products for Human Use of ...
Greenheart Gold Inc. (TSXV: GHRT; OTCQB: GHRTF) (the "Company" or "Greenheart Gold") is pleased to announce that its common shares commenced trading ...
DJT Stock Will Be First Listing on New Texas Exchange SARASOTA, Fla., March 31, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq: DJT) ("TMTG" or the "Company"), operator of the ...
Giftify, Inc. (NASDAQ: GIFT) (the "Company"), the owner and operator of CardCash.com and Restaurant.com, and a leader in the incentives and rewards ...
Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results and ...